Coronavirus [COVID-19] – WHO
Public Health Emergency of International Concern (PHEIC)
Weekly Epidemiological and Operational updates
Last update: 18 Mar 2022
Confirmed cases :: 464 809 377
Confirmed deaths :: 6 062 536
Vaccine doses administered: 10 925 055 390
17 March 2022
WHO Director-General’s opening remarks at the Member State Information Session on COVID-19 – 17 March 2022
16 March 2022
WHO Director-General’s opening remarks at the WHO press conference – 16 March 2022
Weekly epidemiological update on COVID-19 – 15 March 2022
After a consistent decrease in the number of new COVID-19 cases reported globally on a weekly basis since the end of January 2022, during the week of 7 through 13 March 2022, the number of new weekly cases has increased by 8% as compared to the previous week. Across the six WHO regions, over 11 million new cases and just over 43 000 new deaths were reported. As of 13 March 2022, over 455 million confirmed cases and over 6 million deaths have been reported globally.
At the regional level, the Western Pacific Region, the African Region and the European Region reported an increase in new weekly cases of 29%, 12% and 2%, respectively, as compared with the previous week; while a decrease has been reported by the Eastern Mediterranean Region (-24%), the South-East Asia Region (-21%) and the Region of the Americas (-20%).
The number of new weekly deaths decreased globally by 17%. At the regional level, the Western Pacific Region reported an increase in new weekly deaths (+12%), while decreases were reported by the Eastern Mediterranean Region (-49%), the African Region (-41%), Europe Region (-23%), the Region of the Americas and South-East Asia Region (both -15%).
In this edition we provide:
Updates on the new WHO Designation of SARS-CoV-2 Variants
Updates on the geographic distribution of circulating SARS-CoV-2 variants of concern (VOCs), including the spread and prevalence of the Omicron variant.
Special Focus: Contact tracing and quarantine in the context of the Omicron SARS-CoV-2 variant: interim guidance
Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 02 March 2022
[Full scale view available at title link above]
[Updated on 02 March 2022]